Found on pharmacist.com
Group by:
Title Date Type
American Pharmacists Association and Pharmacy Podcast Network Announce Exclusive Collaboration Agreement
WASHINGTON, DC – The American Pharmacists Association (APhA) and the Pharmacy Podcast Network (PPN) today announced that they have entered into agreement where PPN will be the exclusive distributor of “Locked on Pharmacy,” APhA’s podcast series on pharmacy topics. Under the agreement, APhA will…
Sep 29, 2020 Article
APhA Foundation Pinnacle Awards recipients honored for innovations in the medication use process
Rachel Balick, reporter 
The Pinnacle Awards, now in their 23rd year, celebrate significant contributions to the medication use process: increasing patient adherence, reducing adverse drug events, promoting the use of national treatment guidelines, improving patient outcomes, and enhancing communication…
Sep 29, 2020 Article
Advocating for You on Coronavirus
APhA and Joint Statements APhA Hails HHS Announcement Authorizing Pharmacists to Administer COVID-19 Vaccines (September 9, 2020) APhA CEO Remarks on the NASEM Draft Framework for Equitable Allocation of a COVID-19 Vaccine (September 2, 2020) In Major Win, HHS Authorizes Pharmacists to…
Mar 18, 2020 Basic page
Weekly Open Forum Webinars
  Addressing the COVID-19 Crisis: An Open Forum Webinar Series for Pharmacists are weekly webinars conducted every Thursday from 1:00 pm–2:00 pm ET. Each open forum webinar is moderated by APhA President Michael Hogue.   Register for the APhA Weekly Open Forum Webinar (October 1)…
Jul 30, 2020 Basic page
1 in 3 parents won't get influenza vaccines for their child during COVID-19, study finds
CNN (09/28/20) LaMotte, Sandee
A third of parents do not plan to have their children vaccinated against influenza this year, according to the new National Poll on Children's Health, despite the added risk of COVID-19 this year. The survey found that families who did not have their child vaccinated against influenza last year…
Sep 27, 2020 Publication Pharmacy Today Daily Edition
FDA approves first drug to treat group of rare blood disorders in nearly 14 years
FDA News Release (09/25/20)
FDA has approved mepolizumab (Nucala—GlaxoSmithKline) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for 6 months or longer without another identifiable non-blood related cause of the disease. HES is a heterogeneous group of rare disorders associated…
Sep 27, 2020 Publication Pharmacy Today Daily Edition
Under 10% of Americans have COVID-19 antibodies, study finds
New York Times (09/27/20) Albeck-Ripka, Livia; Beech, Hannah; Belluck, Pam; et al.
Fewer than 10% of Americans have COVID-19 antibodies, according to research out of Stanford University. Based on analysis of blood samples from 28,500 dialysis patients nationwide, the scientists calculated that only 9.3% of the population is protected by antibodies, with wide variation by state.…
Sep 27, 2020 Publication Pharmacy Today Daily Edition
Dapagliflozin in patients with CKD
New England Journal of Medicine (09/24/20) Heerspink, Hiddo J.L.; Stefánsson, Bergur V.; Correa-Rotter, Ricardo; et al.
Researchers sought to examine the effect of dapagliflozin in patients with chronic kidney disease (CKD), with or without type 2 diabetes, noting that CKD patients have a high risk of adverse kidney and cardiovascular outcomes. In their study, the investigators randomly assigned 4,304 participants…
Sep 27, 2020 Publication Pharmacy Today Daily Edition
New research finds unapproved drugs in brain-boosting supplements
STAT News (09/23/20) Spinelli, Alexander
A new study of OTC brain supplements published in Neurology found they contained five unapproved pharmaceutical drugs in possibly risky combinations and doses. Pieter Cohen, MD, an associate professor at Harvard Medical school and author of the study, observes: "Not only did we detect unapproved…
Sep 27, 2020 Publication Pharmacy Today Daily Edition
Trump's proposed drug-discount cards will be funded by a Medicare trust fund
Wall Street Journal (09/25/20) Armour, Stephanie
The president will tap into a Medicare trust fund to bankroll his $6 billion plan to issue prescription discount cards to 33 million older adults, according to an administration official. Donald Trump recently announced the card program, which will help individual recipients pay for up to $200 in…
Sep 27, 2020 Publication Pharmacy Today Daily Edition